Matthew Philip Goetz, MD

  • 8838 Citations
  • 43 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2017

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

Opyrchal, M., Malgorzata, G., Salisbury, J. L., Goetz, M. P., Suman, V., Degnim, A., McCubrey, J., Haddad, T., Iankov, I., Kurokawa, C. B., Shumacher, N., Ingle, J. N., Galanis, E. & D'Assoro, A. B., Jan 1 2017, In : Oncotarget. 8, 53, p. 91803-91816 14 p.

Research output: Contribution to journalArticle

9 Scopus citations

MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer

Goetz, M. P., Toi, M., Campone, M., Trédan, O., Bourayou, N., Sohn, J., Park, I. H., Paluch-Shimon, S., Huober, J., Chen, S. C., Manso, L., Barriga, S., Freedman, O. C., Jaliffe, G. G., Forrester, T., Frenzel, M., Smith, I. C. & Di Leo, A., Nov 10 2017, In : Journal of Clinical Oncology. 35, 32, p. 3638-3646 9 p.

Research output: Contribution to journalArticle

310 Scopus citations

NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Isakoff, S. J., Lyons, J., Kelly Marcom, P., Mayer, I. A., McCormick, B., Moran, M. S., O'Regan, R. M., Patel, S. A. & 13 others, Pierce, L. J., Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Sitapati, A., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M., Ward, J. H., Shead, D. A. & Kumar, R., Apr 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 4, p. 433-451 19 p.

Research output: Contribution to journalArticle

Open Access
166 Scopus citations

NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer

Ma, C. X., Gao, F., Luo, J., Northfelt, D. W., Goetz, M. P., Forero, A., Hoog, J., Naughton, M., Ademuyiwa, F., Suresh, R., Anderson, K. S., Margenthaler, J., Aft, R., Hobday, T. J., Moynihan, T., Gillanders, W., Cyr, A., Eberlein, T. J., Hieken, T. J., Krontiras, H. & 14 others, Guo, Z., Lee, M. V., Spies, N. C., Skidmore, Z. L., Griffith, O. L., Griffith, M., Thomas, S., Bumb, C., Vij, K., Huang Bartlett, C., Koehler, M., Al-Kateb, H., Sanati, S. & Ellis, M. J., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4055-4065 11 p.

Research output: Contribution to journalArticle

93 Scopus citations

Neratinib efficacy and circulating tumor DNA detection of HER2 mutations in HER2 nonamplified metastatic breast cancer

Ma, C. X., Bose, R., Gao, F., Freedman, R. A., Telli, M. L., Kimmick, G., Winer, E., Naughton, M., Goetz, M. P., Russell, C., Tripathy, D., Cobleigh, M., Forero, A., Pluard, T. J., Anders, C., Niravath, P. A., Thomas, S., Anderson, J., Bumb, C., Banks, K. C. & 10 others, Lanman, R. B., Bryce, R., Lalani, A. S., Pfeifer, J., Hayes, D. F., Pegram, M., Blackwell, K., Bedard, P. L., Al-Kateb, H. & Ellis, M. J. C., Oct 1 2017, In : Clinical Cancer Research. 23, 19, p. 5687-5695 9 p.

Research output: Contribution to journalArticle

48 Scopus citations

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma

Mc Williams, R. R., Foster, N. R., Mahoney, M. R., Smyrk, T. C., Murray, J. A., Ames, M. M., Horvath, L. E., Schneider, D. J., Hobday, T. J., Jatoi, A., Meyers, J. P. & Goetz, M. P., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

15 Scopus citations
19 Scopus citations

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Bagegni, N., Thomas, S., Liu, N., Luo, J., Hoog, J., Northfelt, D. W., Goetz, M. P., Forero, A., Bergqvist, M., Karen, J., Neumüller, M., Suh, E. M., Guo, Z., Vij, K., Sanati, S., Ellis, M. & Ma, C. X., Nov 21 2017, In : Breast Cancer Research. 19, 1, 123.

Research output: Contribution to journalArticle

16 Scopus citations

Skeletal and uterotrophic effects of endoxifen in female rats

Gingery, A., Iwaniec, U. T., Subramaniam, M., Turner, R. T., Pitel, K. S., McGovern, R. M., Reid, J. M., Marler, R. J., Ingle, J. N., Goetz, M. P. & Hawse, J. R., Oct 1 2017, In : Endocrinology. 158, 10, p. 3354-3368 15 p.

Research output: Contribution to journalArticle

1 Scopus citations

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

Dudenkov, T. M., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Ibrahim-zada, I., Batzler, A., Jenkins, G. D., Pietrzak, T. L., Carlson, E. E., Barman, P., Goetz, M. P., Northfelt, D. W., Moreno-Aspita, A., Williard, C. V., Kalari, K. R., Nakamura, Y., Wang, L. M. & Weinshilboum, R. M., Jul 1 2017, In : Breast Cancer Research and Treatment. 164, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008

Connolly, R. M., Fackler, M. J., Zhang, Z., Zhou, X. C., Goetz, M. P., Boughey, J. C., Walsh, B., Carpenter, J. T., Storniolo, A. M., Watkins, S. P., Gabrielson, E. W., Stearns, V. & Sukumar, S., Sep 16 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-10 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Goetz, M. P., Kalari, K. R., Suman, V. J., Moyer, A. M., Yu, J., Visscher, D. W., Dockter, T. J., Vedell, P. T., Sinnwell, J. P., Tang, X., Thompson, K. J., McLaughlin, S. A., Moreno-Aspitia, A., Copland, J. A., Northfelt, D. W., Gray, R. J., Hunt, K., Conners, A., Weinshilboum, R., Wang, L. & 1 others, Boughey, J. C., Jul 1 2017, In : Journal of the National Cancer Institute. 109, 7, djw306.

Research output: Contribution to journalArticle

23 Scopus citations
2016

A first-in-human phase i study of the oral p38 MAPK inhibitor, ralimetinib (LY2228820 Dimesylate), in patients with advanced cancer

Patnaik, A., Haluska, P., Tolcher, A. W., Erlichman, C., Papadopoulos, K. P., Lensing, J. L., Beeram, M., Molina, J. R., Rasco, D. W., Arcos, R. R., Kelly, C. S., Wijayawardana, S. R., Zhang, X., Stancato, L. F., Bell, R., Shi, P., Kulanthaivel, P., Pitou, C., Mulle, L. B., Farrington, D. L. & 2 others, Chan, E. M. & Goetz, M. P., Mar 1 2016, In : Clinical Cancer Research. 22, 5, p. 1095-1102 8 p.

Research output: Contribution to journalArticle

33 Scopus citations

Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy

Park, J. H., Jang, M., Tarhan, Y. E., Katagiri, T., Sasa, M., Miyoshi, Y., Kalari, K. R., Suman, V. J., Weinshilboum, R. M., Wang, L. M., Boughey, J. C., Goetz, M. P. & Nakamura, Y., Aug 1 2016, In : International Journal of Oncology. 49, 2, p. 471-478 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Estrogen, SNP-dependent chemokine expression and selective estrogen receptor modulator regulation

Ho, M. F., Bongartz, T., Liu, M., Kalari, K. R., Goss, P. E., Shepherd, L. E., Goetz, M. P., Kubo, M., Ingle, J. N., Wang, L. & Weinshilboum, R. M., Mar 2016, In : Molecular Endocrinology. 30, 3, p. 382-398 17 p.

Research output: Contribution to journalArticle

17 Scopus citations

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Yoon, H. H., Foster, N. R., Meyers, J. P., Steen, P. D., Visscher, D. W., Pillai, R., Prow, D. M., Reynolds, C. M., Marchello, B. T., Mowat, R. B., Mattar, B. I., Erlichman, C. & Goetz, M. P., Feb 1 2016, In : Annals of Oncology. 27, 2, p. 339-344 6 p., mdv543.

Research output: Contribution to journalArticle

18 Scopus citations

Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy

Ingle, J. N., Xie, F., Ellis, M. J., Goss, P. E., Shepherd, L. E., Chapman, J. A. W., Chen, B. E., Kubo, M., Furukawa, Y., Momozawa, Y., Stearns, V., Pritchard, K. I., Barman, P., Carlson, E. E., Goetz, M. P., Weinshilboum, R. M., Kalari, K. R. & Wang, L., Dec 1 2016, In : Cancer research. 76, 23, p. 7012-7023 12 p.

Research output: Contribution to journalArticle

19 Scopus citations

Phase i Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Tan, W., Allred, J. B., Moreno Aspitia, A., Northfelt, D. W., Ingle, J. N., Goetz, M. P. & Perez, E. A., Apr 1 2016, In : Clinical Breast Cancer. 16, 2, p. 82-86 5 p.

Research output: Contribution to journalArticle

17 Scopus citations
2015

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

Polo, M. L., Riggio, M., May, M., Rodríguez, M. J., Perrone, M. C., Stallings-Mann, M., Kaen, D., Frost, M., Goetz, M. P., Boughey, J. C., Lanari, C., Radisky, D. C. & Novaro, V., 2015, In : Oncotarget. 6, 26, p. 22081-22097 17 p.

Research output: Contribution to journalArticle

9 Scopus citations

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

Vachon, C. M., Schaid, D. J., Ingle, J. N., Wickerham, D. L., Kubo, M., Mushiroda, T., Goetz, M. P., Carlson, E. E., Paik, S., Wolmark, N., Nakamura, Y., Wang, L., Weinshilboum, R. & Couch, F. J., Jan 1 2015, In : Breast Cancer Research and Treatment. 149, 2, p. 517-523 7 p.

Research output: Contribution to journalArticle

16 Scopus citations

Breast cancer, version 1.2016 featured updates to the NCCN guidelines

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Marcom, P. K., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., Pierce, L. J. & 11 others, Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M., Ward, J. H., Shead, D. A. & Kumar, R., Dec 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 12, p. 1475-1485 11 p.

Research output: Contribution to journalArticle

Open Access
99 Scopus citations

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

Safgren, S. L., Suman, V. J., Kosel, M. L., Gilbert, J. A., Buhrow, S. A., Black, J. L., Northfelt, D. W., Modak, A. S., Rosen, D., Ingle, J. N., Ames, M. M., Reid, J. M. & Goetz, M. P., Mar 27 2015, In : Pharmacogenetics and genomics. 25, 4, p. 157-163 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Ellingson, M. S., Hart, S. N., Kalari, K. R., Suman, V., Schahl, K. A., Dockter, T. J., Felten, S. J., Sinnwell, J. P., Thompson, K. J., Tang, X., Vedell, P. T., Barman, P., Sicotte, H., Eckel-Passow, J. E., Northfelt, D. W., Gray, R. J., McLaughlin, S. A., Moreno-Aspitia, A., Ingle, J. N., Moyer, A. M. & 9 others, Visscher, D. W., Jones, K., Conners, A., McDonough, M., Wieben, E. D., Wang, L., Weinshilboum, R., Boughey, J. C. & Goetz, M. P., Sep 7 2015, In : Breast Cancer Research and Treatment. 153, 2, p. 435-443 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Loss of heterozygosity at the CYP2D6 locus in breast cancer: Implications for germline pharmacogenetic studies

Goetz, M. P., Sun, J. X., Suman, V. J., Silva, G. O., Perou, C. M., Nakamura, Y., Cox, N. J., Stephens, P. J., Miller, V. A., Ross, J. S., Chen, D., Safgren, S. L., Kuffel, M. J., Ames, M. M., Kalari, K. R., Gomez, H. L., Gonzalez-Angulo, A. M., Burgues, O., Brauch, H. B., Ingle, J. N. & 2 others, Ratain, M. J. & Yelensky, R., Feb 1 2015, In : Journal of the National Cancer Institute. 107, 2, dju401.

Research output: Contribution to journalArticle

34 Scopus citations

TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

Connolly, R. M., Leal, J. P., Goetz, M. P., Zhang, Z., Zhou, X. C., Jacobs, L. K., Mhlanga, J., Joo, H. O., Carpenter, J., Storniolo, A. M., Watkins, S., Fetting, J. H., Miller, R. S., Sideras, K., Jeter, S. C., Walsh, B., Powers, P., Zorzi, J., Boughey, J. C., Davidson, N. E. & 6 others, Carey, L. A., Wolff, A. C., Khouri, N., Gabrielson, E., Wahl, R. L. & Stearns, V., Jan 1 2015, In : Journal of Nuclear Medicine. 56, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline

Van Poznak, C., Somerfield, M. R., Bast, R. C., Cristofanilli, M., Goetz, M. P., Gonzalez-Angulo, A. M., Hicks, D. G., Hill, E. G., Liu, M. C., Lucas, W., Mayer, I. A., Mennel, R. G., Symmans, W. F., Hayes, D. F. & Harris, L. N., Aug 20 2015, In : Journal of Clinical Oncology. 33, 24, p. 2695-2704 10 p.

Research output: Contribution to journalArticle

148 Scopus citations
2014

Androgen receptor-positive triple negative breast cancer: A unique breast cancer subtype

McGhan, L. J., McCullough, A. E., Protheroe, C. A., Dueck, A. C., Lee, J. J., Nunez-Nateras, R., Castle, E. P., Gray, R. J., Wasif, N., Goetz, M. P., Hawse, J. R., Henry, T. J., Barrett, M. T., Cunliffe, H. E. & Pockaj, B. A., Feb 1 2014, In : Annals of surgical oncology. 21, 2, p. 361-367 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells

Opyrchal, M., Salisbury, J. L., Zhang, S., McCubrey, J., Hawse, J., Goetz, M. P., Lomberk, G. A., Haddad, T., Degnim, A., Lange, C., Ingle, J. N., Galanis, E. & D'Assoro, A. B., May 9 2014, In : PloS one. 9, 5, e96995.

Research output: Contribution to journalArticle

14 Scopus citations

Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats

Schweikart, K. M., Eldridge, S. R., Safgren, S. L., Parman, T., Reid, J. M., Ames, M. M., Goetz, M. P. & Davis, M. A., Dec 2014, In : Toxicologic Pathology. 42, 8, p. 1188-1196 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations

Province, M. A., Goetz, M. P., Brauch, H., Flockhart, D. A., Hebert, J. M., Whaley, R., Suman, V. J., Schroth, W., Winter, S., Zembutsu, H., Mushiroda, T., Newman, W. G., Lee, M. T. M., Ambrosone, C. B., Beckmann, M. W., Choi, J. Y., Dieudonné, A. S., Fasching, P. A., Ferraldeschi, R., Gong, L. & 44 others, Haschke-Becher, E., Howell, A., Jordan, L. B., Hamann, U., Kiyotani, K., Krippl, P., Lambrechts, D., Latif, A., Langsenlehner, U., Lorizio, W., Neven, P., Nguyen, A. T., Park, B. W., Purdie, C. A., Quinlan, P., Renner, W., Schmidt, M., Schwab, M., Shin, J. G., Stingl, J. C., Wegman, P., Wingren, S., Wu, A. H. B., Ziv, E., Zirpoli, G., Thompson, A. M., Jordan, V. C., Nakamura, Y., Altman, R. B., Ames, M. M., Weinshilboum, R. M., Eichelbaum, M., Ingle, J. N., Klein, T. E., Boländer, J., Ulmer, H. U., Fischer-Bosch, M., Fritz, P., Simon, W., Bryan, Y., Strick, R., Koelbl, H., Ambrosone, C. A. & H, E. Z., Feb 1 2014, In : Clinical pharmacology and therapeutics. 95, 2, p. 216-227 12 p.

Research output: Contribution to journalArticle

115 Scopus citations

ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Reese, J. M., Suman, V. J., Subramaniam, M., Wu, X., Negron, V., Gingery, A., Pitel, K. S., Shah, S. S., Cunliffe, H. E., McCullough, A. E., Pockaj, B. A., Couch, F. J., Olson, J. E., Reynolds, C., Lingle, W. L., Spelsberg, T. C., Goetz, M. P., Ingle, J. N. & Hawse, J. R., Oct 7 2014, In : BMC cancer. 14, 1, 749.

Research output: Contribution to journalArticle

27 Scopus citations

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

Ingle, J. N., Kalari, K. R., Buzdar, A. U., Robson, M. E., Goetz, M. P., Desta, Z., Barman, P., Dudenkov, T. T., Northfelt, D. W., Perez, E. A., Flockhart, D. A., Williard, C. V., Wang, L. M. & Weinshilboum, R. M., May 1 2014, (Accepted/In press) In : Steroids.

Research output: Contribution to journalArticle

23 Scopus citations

Inhibition of Cdk2 kinase activity selectively targets the CD44 +/CD24-/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

Opyrchal, M., Salisbury, J. L., Iankov, I., Goetz, M. P., McCubrey, J., Gambino, M. W., Malatino, L., Puccia, G., Ingle, J. N., Galanis, E. & D'Assoro, A. B., Sep 2014, In : International journal of oncology. 45, 3, p. 1193-1199 7 p.

Research output: Contribution to journalArticle

28 Scopus citations

Once-daily radiation therapy for inflammatory breast cancer

Brown, L., Harmsen, W., Blanchard, M., Goetz, M., Jakub, J., Mutter, R., Petersen, I., Rooney, J., Stauder, M., Yan, E. & Laack, N., Aug 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 5, p. 997-1003 7 p.

Research output: Contribution to journalArticle

11 Scopus citations

Pharmacokinetics of endoxifen and tamoxifen in female mice: Implications for comparative in vivo activity studies

Reid, J. M., Goetz, M. P., Buhrow, S. A., Walden, C., Safgren, S. L., Kuffel, M. J., Reinicke, K. E., Suman, V., Haluska, P., Hou, X. & Ames, M. M., Oct 9 2014, In : Cancer chemotherapy and pharmacology. 74, 6, p. 1271-1278 8 p.

Research output: Contribution to journalArticle

14 Scopus citations
16 Scopus citations

The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton

Gingery, A., Subramaniam, M., Pitel, K. S., Reese, J. M., Cicek, M., Lindenmaier, L. B., Ingle, J. N., Goetz, M. P., Turner, R. T., Iwaniec, U. T., Spelsberg, T. C. & Hawse, J. R., May 22 2014, In : PloS one. 9, 5, e98219.

Research output: Contribution to journalArticle

4 Scopus citations
2013

A phase i trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer

Ma, C. X., Suman, V. J., Goetz, M., Haluska, P., Moynihan, T., Nanda, R., Olopade, O., Pluard, T., Guo, Z., Chen, H. X., Erlichman, C., Ellis, M. J. & Fleming, G. F., May 1 2013, In : Breast Cancer Research and Treatment. 139, 1, p. 145-153 9 p.

Research output: Contribution to journalArticle

47 Scopus citations

CYP2D6 metabolism and patient outcome in the Austrian breast and colorectal cancer study group trial (ABCSG) 8

Goetz, M. P., Suman, V. J., Hoskin, T. L., Gnant, M., Filipits, M., Safgren, S. L., Kuffel, M., Jakesz, R., Rudas, M., Greil, R., Dietze, O., Lang, A., Offner, F., Reynolds, C. A., Weinshilboum, R. M., Ames, M. M. & Ingle, J. N., Jan 15 2013, In : Clinical Cancer Research. 19, 2, p. 500-507 8 p.

Research output: Contribution to journalArticle

81 Scopus citations

Endoxifen's Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens

Hawse, J. R., Subramaniam, M., Cicek, M., Wu, X., Gingery, A., Grygo, S. B., Sun, Z., Pitel, K. S., Lingle, W. L., Goetz, M. P., Ingle, J. N. & Spelsberg, T. C., Jan 28 2013, In : PloS one. 8, 1, e54613.

Research output: Contribution to journalArticle

34 Scopus citations

Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

Khurana, A., Jung-Beom, D., He, X., Kim, S. H., Busby, R. C., Lorenzon, L., Villa, M., Baldi, A., Molina, J., Goetz, M. P. & Shridhar, V., Apr 1 2013, In : Clinical and Experimental Metastasis. 30, 4, p. 407-415 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2–overexpressing breast cancer: TBCRC 006

Rimawi, M. F., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Rodriguez, A. A., Pavlick, A. C., Wang, T., Hilsenbeck, S. G., Gutierrez, C., Schiff, R., Osborne, C. K. & Chang, J. C., May 10 2013, In : Journal of Clinical Oncology. 31, 14, p. 1726-1731 6 p.

Research output: Contribution to journalArticle

168 Scopus citations

Percutaneous image-guided cryoablation of painful metastases involving bone: Multicenter trial

Callstrom, M. R., Dupuy, D. E., Solomon, S. B., Beres, R. A., Littrup, P. J., Davis, K. W., Paz-Fumagalli, R., Hoffman, C., Atwell, T. D., Charboneau, J. W., Schmit, G. D., Goetz, M. P., Rubin, J., Brown, K. J., Novotny, P. J. & Sloan, J. A., Mar 1 2013, In : Cancer. 119, 5, p. 1033-1041 9 p.

Research output: Contribution to journalArticle

152 Scopus citations

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: Individualized breast cancer prevention

Ingle, J. N., Liu, M., Lawrence Wickerham, D., Schaid, D. J., Wang, L., Mushiroda, T., Kubo, M., Costantino, J. P., Vogel, V. G., Paik, S., Goetz, M. P., Ames, M. M., Jenkins, G. D., Batzler, A., Carlson, E. E., Flockhart, D. A., Wolmark, N., Nakamura, Y. & Weinshilboum, R. M., Jul 1 2013, In : Cancer discovery. 3, 7, p. 812-825 14 p.

Research output: Contribution to journalArticle

36 Scopus citations

TSPYl5 SNPs: Association with plasma estradiol concentrations and aromatase expression

Liu, M., Ingle, J. N., Fridley, B. L., Buzdar, A. U., Robson, M. E., Kubo, M., Wang, L., Batzler, A., Jenkins, G. D., Pietrzak, T. L., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Perez, E. A., Williard, C. V., Schaid, D. J., Nakamura, Y. & Weinshilboum, R. M., Apr 1 2013, In : Molecular Endocrinology. 27, 4, p. 657-670 14 p.

Research output: Contribution to journalArticle

32 Scopus citations

UGT1A1 genotype-guided phase i study of irinotecan, oxaliplatin, and capecitabine

Goetz, M. P., McKean, H. A., Reid, J. M., Mandrekar, S. J., Tan, A. D., Kuffel, M. A., Safgren, S. L., McGovern, R. M., Goldberg, R. M., Grothey, A. A., McWilliams, R., Erlichman, C. & Ames, M. M., Dec 1 2013, In : Investigational New Drugs. 31, 6, p. 1559-1567 9 p.

Research output: Contribution to journalArticle

8 Scopus citations

Update on CYP2D6 and tamoxifen

Goetz, M. P., Apr 1 2013, In : Clinical Advances in Hematology and Oncology. 11, 4, p. 178-180 3 p.

Research output: Contribution to journalArticle

1 Scopus citations
2012

Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record

Savova, G. K., Olson, J. E., Murphy, S. P., Cafourek, V. L., Couch, F. J., Goetz, M. P., Ingle, J. N., Suman, V. J., Chute, C. G. & Weinshilboum, R. M., Jun 1 2012, In : Journal of the American Medical Informatics Association. 19, E1, p. e83-e89

Research output: Contribution to journalArticle

19 Scopus citations

Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody

Wu, X., Subramaniam, M., Negron, V., Cicek, M., Reynolds, C., Lingle, W. L., Goetz, M. P., Ingle, J. N., Spelsberg, T. C. & Hawse, J. R., Feb 1 2012, In : Journal of cellular biochemistry. 113, 2, p. 711-723 13 p.

Research output: Contribution to journalArticle

34 Scopus citations